Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03428490 · ClinicalTrials.gov registry record · NA

Treatment for Comorbid Social Anxiety and Alcohol Use Disorders.

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
56
Enrollment target

NCT03428490 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 56 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03428490, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target

Study Summary

Alcohol use disorders (AUD) and social anxiety disorder (SAD) are highly comorbid and associated with significant impairment. Social anxiety comorbidity is associated with poorer addiction treatment engagement and outcomes. Thus, addressing underlying SAD symptoms that may lead to and maintain alcohol problems, as well as undermine successful treatment for AUD, is warranted. This proposal aims to develop and evaluate a fully integrated outpatient program for comorbid SAD and AUD that weaves evidence-based treatment for SAD (i.e., exposure-based cognitive behavioral therapy) into a traditional, evidence-based treatment for AUD. First, the investigators will develop the protocol for the fully integrated treatment (FIT). The overarching goal of FIT will be to simultaneously deliver AUD and SAD treatment. Development will be an iterative process guided by previous research (including our own), and by input from clinicians, administrators, and patients in an outpatient substance use disorder treatment clinic. After the protocol is developed, the investigators will use their established clinician training procedures to train clinicians at their community partnered clinic to competently deliver the intervention. After protocol development and clinician training, the investigators will conduct a pilot randomized clinical trial (RCT) comparing the efficacy of our fully integrated treatment (FIT) for comorbid alcohol use and social anxiety disorders to usual care (UC) in the community substance use disorder specialty clinic. The goals of the RCT will be to gather data regarding acceptability, feasibility, and preliminary efficacy of the FIT protocol. The investigators will randomize treatment-seeking participants (N = 60) who have comorbid SAD and AUD. The investigators will assess treatment engagement, social anxiety outcomes, and alcohol use outcomes at baseline, 3-months, and 6-months from baseline. The investigators will also gather qualitative and quantitative acceptabi

Interventions

  • BEHAVIORAL Fully integrated treatment
  • BEHAVIORAL Stand-alone Intensive Outpatient Program

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2018-03-15
Est. Completion 2021-04-30
Phase NA

What the Registry Record Tells You About NCT03428490

The ClinicalTrials.gov registry entry for NCT03428490 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Fully integrated treatment is the first listed.

NCT03428490 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03428490 about?

NCT03428490 is a clinical study titled "Treatment for Comorbid Social Anxiety and Alcohol Use Disorders.". Alcohol use disorders (AUD) and social anxiety disorder (SAD) are highly comorbid and associated with significant impairment. Social anxiety comorbidity is associated with poorer addiction treatment engagement and outcomes. Thus, addressing underlying SAD symptoms that may lead to and maintain alcoh...

What is the current status of trial NCT03428490?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2018-03-15. Estimated completion is 2021-04-30.

What interventions are being tested in trial NCT03428490?

The interventions under investigation include: Fully integrated treatment (BEHAVIORAL), Stand-alone Intensive Outpatient Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT03428490?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.